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Bradykinin and ATP Accelerate Ca2 Efflux
from Rat Sensory Neurons via Protein Kinase C
and the Plasma Membrane Ca2 Pump Isoform 4
PMCAs play a special role in sensory function. They
are the primary mechanism for Ca2 expulsion from the
somata of dorsal root ganglion (DRG) neurons (Benham
et al., 1992; Werth et al., 1996) and from the presynaptic
terminals of photoreceptors (Krizaj and Copenhagen,
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thews, 2000). PMCA2 extrudes Ca2 from hair cell ste-321 Church Street SE
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Mayo Clinic phosphorylated by protein kinase A (PKA) and protein
kinase C (PKC) (Kosk-Kosicka and Zylinska, 1997; Wang200 First Street SW
Rochester, Minnesota 55905 et al., 1992). The site of phosphorylation varies among
PMCA isoforms, and alternative splicing of primary tran-
scripts alters its presence and position (Strehler and
Zacharias, 2001). Thus, neuromodulators that stimulateSummary
PKA or PKC are predicted to modify PMCA-mediated
Ca2 transport in an isoform-specific manner, althoughModulation of Ca2 channels by neurotransmitters pro-
vides critical control of neuronal excitability and synaptic this idea has not previously been tested.
Bradykinin is a potent pain-producing peptide that isstrength. Little is known about regulation of the Ca2
efflux pathways that counterbalance Ca2 influx in neu- generated at sites of tissue damage and inflammation
(Dray and Perkins, 1993). ATP is a key neurotransmitterrons. We demonstrate that bradykinin and ATP signifi-
cantly facilitate removal of action potential-induced Ca2 in the sensory nervous system involved in the transduc-
tion of pain and proprioception (Cook et al., 1997; Naka-loads by stimulating plasma membrane Ca2-ATPases
(PMCAs) in rat sensory neurons. This effect was mim- mura and Strittmatter, 1996). Both bradykinin and ATP
control excitability in sensory neurons through mecha-icked in the soma and axonal varicosities by phorbol
esters and was blocked by antagonists of protein ki- nisms that are not fully understood. These agonists acti-
vate metabotropic receptors that couple to phospholi-nase C (PKC). Reduced expression of PMCA isoform
4 abolished, and overexpression of isoform 4b en- pase C (Burgess et al., 1989; Ralevic and Burnstock,
1998; Thayer et al., 1988). Because bradykinin and ATPhanced, PKC-dependent facilitation of Ca2 efflux. This
acceleration of PMCA4 underlies the shortening of the stimulate PKC-dependent pathways and PMCAs are po-
tentially phosphorylated by PKC, we tested the hypothe-action potential afterhyperpolarization produced by
activation of bradykinin and purinergic receptors. sis that bradykinin and ATP would modulate Ca2 efflux
in DRG neurons.Thus, isoform-specific modulation of PMCA-mediated
Ca2 efflux represents a novel mechanism to control We found that these neuromodulators accelerated Ca2
efflux via PKC in a manner that was dependent on theexcitability in sensory neurons.
expression of a particular PMCA isoform. Bradykinin and
an ATP analog reduced the duration of the action potentialIntroduction
afterhyperpolarization (AHP) by facilitating PMCA-medi-
ated Ca2 efflux. Therefore, modulation of PMCAs by neu-Intracellular Ca2 concentration ([Ca2]i) controls a num-
ber of neuronal functions, including excitability, neuro- rotransmitters and neuroactive peptides participates in
the control of neuronal excitability.transmitter release, gene expression, and neurotoxicity
(Ghosh and Greenberg, 1995). Ca2 entering the cell
during excitation must be efficiently removed from the Results
cytoplasm to maintain normal Ca2 homeostasis. The
plasma membrane Ca2-ATPases (PMCAs) are key com- PMCA-Mediated Ca2 Efflux in Rat DRG Neurons
ponents of the Ca2 extrusion machinery in neurons In DRG neurons, high affinity Ca2 pumps of the endo-
(Miller, 1991). The four PMCA gene products are hetero- plasmic reticulum and plasma membrane are the princi-
geneously distributed in brain and are present in the pal mechanisms that control [Ca2]i recovery to basal
soma, presynaptic terminals, dendrites, and dendritic levels after small Ca2 loads (Benham et al., 1992; Usa-
spines (Carafoli, 1994; Filoteo et al., 1997; Juhaszova et chev and Thayer, 1999; Werth et al., 1996). Monitoring
al., 2000; Stauffer et al., 1995). The high affinity of PMCAs PMCA-mediated Ca2 efflux is hampered by the ab-
for Ca2 (0.2–0.6 M) (Wang et al., 1992) and their colo- sence of selective inhibitors and a relatively low turnover
calization with voltage-gated Ca2 channels (Hillman et rate of the pump, making electrophysiological detection
al., 1996) make these pumps ideally suited to lower of this transport unfeasible. PMCA-mediated Ca2 efflux
[Ca2]i following bursts of electrical activity. from DRG somata was studied in isolation by limiting
the size of the [Ca2]i increase to less than 350 nM
and by blocking the sarco-endoplasmic reticulum Ca2-3 Correspondence: thayer@med.umn.edu
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Figure 1. The Rate of Ca2 Efflux in DRG Neurons Remains Stable
during the Recording and Is Independent of the Amplitude of the Figure 2. Elevated Extracellular pH and Vanadate Inhibit Ca2 Efflux
[Ca2]i Response and Prolong the Action Potential AHP in DRG Neurons
(A) A protocol for studying PMCA-mediated [Ca2]i recovery kinetics. (A) The effect of extracellular pH was studied in DRG neurons loaded
[Ca2]i was recorded as described in Experimental Procedures. CPA with indo-1 AM. [Ca2]i transients were elicited using extracellular
(horizontal bar) and electric field stimulation (4 s, 8 Hz; black arrow- field stimulation in the presence of 5M CPA. Two [Ca2]i responses
heads) were applied at the times indicated. obtained from the same cell are superimposed. The control trace
(B) The [Ca2]i transient indicated by the vertical arrow in (A) is was recorded at normal pH (7.35). Increasing extracellular pH to 8.8
displayed (dotted line) on an expanded time scale. The recovery (horizontal bar) blocked [Ca2]i recovery in five of eight cells tested
phase of the [Ca2]i response was fit with a monoexponential func- and greatly slowed it in the other three cells. Return to pH 7.35
tion (solid line) as described in Experimental Procedures. restored the recovery process.
(C) Rate constants obtained from five independent experiments (B) [Ca2]i measurements were combined with patch-clamp re-
such as those described in (A) were averaged and plotted versus cording using the current-clamp configuration. Small Ca2 loads
time (mean  SEM). The first stimulation was at time 0. were elicited by brief trains of action potentials in the presence of
(D) Rate constants are plotted versus the amplitude of the corre- 5M CPA. A control [Ca2]i trace is superimposed with one obtained
sponding [Ca2]i increase for four individual cells. Each neuron is from a cell with 200 M Na3VO4 added to the pipette solution.
represented by a unique symbol. (C) Bar graph summarizes rate constants obtained from 12 control
cells and 10 cells treated with VO43 as described in (B). (***p 
0.001, unpaired Student’s t test.)
(D) AHPs following a burst of action potentials in the absence andATPase (SERCA) with 5 M cyclopiazonic acid (CPA)
presence of vanadate are compared. Voltage traces were obtained(Thomas and Hanley, 1994). CPA evoked a transient
in the presence of 5 M CPA using the current-clamp mode. Actionelevation in [Ca2]i from 58  3 to 204  10 nM (n  25; potential amplitude was truncated. Introduction of 200 M VO43Figure 1A) that recovered to a new steady-state level of through the patch pipette markedly slowed recovery of the AHP.
73  5 nM (n  25) within 10–25 min. Thus, PMCA- (E) Bar graph summarizes the AHP recovery rate from 12 control
mediated Ca2 efflux was studied 30 min after CPA treat- cells and 10 cells treated with VO43 as described in (D). The recovery
of the AHP was fit with a monoexponential function as describedment. Transient [Ca2]i elevations were elicited every 4
in Experimental Procedures. (*p  0.05, unpaired Student’s t test.)min by brief trains of action potentials (3–5 s, 5–10 Hz)
using extracellular field stimulation (Figure 1A). [Ca2]i
recovery was well described by a monoexponential
function (correlation coefficient  0.97; Figure 1B). The To verify that the rate of [Ca2]i recovery in this para-
digm was predominantly controlled by PMCA activity,rate constant (k), a value reciprocal to the time constant,
was calculated for each [Ca2]i transient and used as we inhibited PMCA function and then recorded the effect
on [Ca2]i recovery kinetics. Ca2 transport by PMCAsan index of Ca2 efflux rate. The rate of Ca2 efflux was
stable throughout the experiment; k was 2.2 0.4 min1 requires counter-transport of protons and thus is inhib-
ited by raising external pH (Benham et al., 1992;for the first [Ca2]i response and 2.3  0.4 min1 (n 
5) for the tenth response 36 min later. The rate of Ca2 Schwiening et al., 1993). [Ca2]i recovery in DRG neurons
was dramatically slowed at pH 8.8 (Figure 2A). Vanadateefflux was not influenced by the size of the Ca2 load
applied in this study (range 50–350 nM) (Figure 1D). acts on an intracellular site of the PMCA to inhibit Ca2
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transport (Carafoli, 1994). [Ca2]i recording was com-
bined with the whole-cell patch-clamp technique to test
the effect of vanadate on Ca2 efflux. [Ca2]i transients
recorded under these conditions (Figure 2B) were similar
(k  2.8  0.4 min1; n  12) to those obtained from
intact cells. Addition of 200 M Na-orthovanadate to
the pipette solution resulted in a more than 9-fold slow-
ing of Ca2 efflux (Figures 2B and 2C), so that the rate
constant decreased to 0.3  0.1 min1 (n  10).
To determine whether PMCAs participate in the con-
trol of membrane excitability, we studied the effects of
vanadate on the action potential AHP. The slow AHP is
produced by Ca2-activated K channels in DRG neu-
rons (Sah, 1996) and, therefore, is tightly linked to intra-
cellular Ca2 homeostasis. Following a train of action
potentials, 68% (n  31) of DRG neurons displayed a
slow AHP. As shown in Figures 2D and 2E, 200 M Na-
orthovanadate significantly decreased the AHP recovery
rate in DRG neurons (7.6  2.1 min1 in control [n  12]
and 2.9  0.3 min1 in vanadate-treated cells [n  10]).
Thus, PMCA-mediated Ca2 efflux controls the duration
of the slow AHP.
The recovery kinetics for the small Ca2 loads used
in this study were not influenced by Na/Ca2 exchange
or mitochondrial Ca2 uptake. [Ca2]i transients evoked
by depolarization (60 to 10 mV, 10 ms, 10 Hz) in the
whole-cell configuration of the patch clamp had similar
recovery rates in Na-containing (k  2.2  0.2 min1;
n  5) and Na-free solution (2.3  0.5 min1; n  5)
(data not shown). Elevating intracellular Na with 200
M ouabain was also without effect on recovery from
action potential-induced Ca2 loads in intact cells (n 
6). Treating cells with mitochondrial poisons blocks mi- Figure 3. Stimulation of PKC Facilitates Ca2 Efflux
tochondria-mediated Ca2 buffering of large Ca2 loads (A) Representative recording of [Ca2]i before and during treatment
(Werth and Thayer, 1994), but did not alter [Ca2]i recov- with 0.5 M PDBu (horizontal bar). Ca2 efflux rate was studied in
ery kinetics in the field stimulation paradigm used here. indo-1 AM-loaded DRG neurons. Small Ca2 loads were elicited
every 4 min in CPA-treated cells (5 M) using extracellular fieldThe rate constant was 2.2  0.4 min1 (n  6) before
stimulation.and 2.3 0.3 min1 (n 6) after treatment with carbonyl
(B) [Ca2]i responses recorded before (control) and after treatmentcyanide p-trifluomethoxy phenyl hydrazone (FCCP; 1
with PDBu (vertical arrows in [A]) are superimposed on an expanded
M) and oligomycin B (10 M). Thus, with SERCAs time scale.
blocked, PMCA-mediated Ca2 efflux was the dominant (C) The effect of 0.5 M PDBu (horizontal bar) on the normalized
mechanism that determined [Ca2]i recovery kinetics in rate constant is summarized for 14 cells (). The PDBu-induced
stimulation of Ca2 efflux was completely blocked by 5 MDRG neurons following small Ca2 loads.
GF109203x (GF, ) or 2 M Ro31-8220 (Ro, ) (for t  20 min,
p  0.001, one-way ANOVA with Bonferroni post hoc test). PKC
Stimulation of PKC Accelerates Ca2 Efflux antagonists were applied 30 min prior to the first field stimulation.
Having established a paradigm to measure PMCA-medi- (D) Axonal varicosities were studied in DRG-spinal neuron cocul-
ated Ca2 efflux, we next examined the effects of PKA tures. Synaptophysin (Syn) immunoreactivity was present in the vari-
cosities of a GFP-expressing neuron as evident in the merged image.and PKC activation on [Ca2]i recovery kinetics. After
(E) [Ca2]i was recorded from the fura-2-loaded axon shown. [Ca2]i30 min in CPA, four action potential-induced increases
responses from the varicosities identified by the arrows are shownin [Ca2]i were elicited to establish control recovery ki- before and after 10 min treatment with 0.5 M PDBu.
netics (Figure 3A). Activation of PKA by treating cells
with membrane permeant analogs of cyclic AMP (1 mM
8-Br-cAMP [n  8] or 100 M pCPT-cAMP [n  6]) did 14). The effect of PDBu was maximal because increasing
the concentration to 2 M produced a comparable in-not affect the rate of Ca2 efflux (data not shown). In
contrast, activation of PKC using 0.5 M phorbol- crease in the rate of Ca2 efflux (k  143%  5% of
control; n  3). The effect of PDBu was blocked com-12,13-dibutyrate (PDBu) markedly accelerated the [Ca2]i
recovery process (Figure 3). Because the rate constant pletely by the selective PKC antagonists GF109203x (5
M; n  5) or Ro31-8220 (2 M; n  4) (Figure 3C). Theof Ca2 efflux varied substantially among DRG neurons
(range, 1–4 min1), in order to pool data from multiple antagonists did not significantly affect the basal rate of
Ca2 efflux, and the potentiation of Ca2 efflux did notcells, the rate constant for each [Ca2]i transient was
normalized to that calculated for the first (control) tran- correlate with the initial rate constant. Phorbol-12-myris-
tate-13-acetate (PMA, 1 M), but not its inactive analogsient for each cell. After treatment with PDBu for 24 min,
the rate constant reached 146%  5% of control (n  4-	-PMA (1 M), also substantially increased the rate
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of Ca2 efflux. After 24 min of treatment with PMA, the
rate constant reached 140%  8% of control (n  5),
whereas for 4-	-PMA it was 104%  3% of control (n
5). Although most recordings were obtained in young
DRG neurons (2–3 days in culture), we found a similar
PKC-dependent facilitation of Ca2 efflux (k  161% 
12% of control; n  7) in 14- to 18-day-old cultures.
Activation of PKC also accelerated [Ca2]i recovery in
DRG axons as indicated by fura-2-based digital imaging.
Varicosities on sensory axons release neurotransmitters
and neuropeptides (Kessler et al., 1999), consistent with
the synaptophysin immunoreactivity present in these
structures (Figure 3D). PDBu (0.5 M) increased the rate
of recovery from action potential-induced increases in
[Ca2]i recorded from these release sites (Figure 3E).
The rate constant increased to 179%  25% of control
(n  14 varicosities from four cells). The acceleration of
Ca2efflux was inhibited completely by 5M GF109203x
(n  9 varicosities from three cells; p  0.05, Student’s
t test).
ATP and Bradykinin Induce PKC-Dependent
Facilitation of Ca2 Efflux
Because activation of PKC by phorbol esters acceler-
ated Ca2 efflux, we hypothesized that neurotransmit-
ters or neuropeptides that activate phospholipase C
would elicit similar effects. A subset of DRG neurons
expresses receptors for bradykinin that, when activated,
stimulate the production of diacylglycerol (DAG) with
subsequent activation of PKC (Burgess et al., 1989; Ces-
are et al., 1999; Thayer et al., 1988). Therefore, we deter-
mined whether bradykinin accelerates Ca2 extrusion
from DRG neurons. In each experiment, bradykinin was
applied twice. The first application was used to identify
a responsive cell by monitoring bradykinin-induced Ca2
Figure 4. Bradykinin and ATP Accelerate Ca2 Efflux from DRG mobilization (Stucky et al., 1996). The second treatment
Neurons examined the effect of bradykinin on the Ca2 efflux
(A) [Ca2]i was recorded with fura-2-based digital imaging from small rate in a responsive cell. To minimize desensitization of
(21 m) DRG neurons cultured for 2–7 days. The horizontal bars
bradykinin receptors (Dray and Perkins, 1993), a sub-indicate application of 30 or 100 nM bradykinin. The break between
maximal concentration of bradykinin (30 nM) was usedthe recordings corresponds to 20 min. A cell was considered respon-
for the first application and a saturating concentrationsive if 30 nM bradykinin evoked an increase in [Ca2]i that was both
greater than 100 nM and at least 50% above baseline (Stucky et (100 nM) for the second. As shown in Figure 4A, when
al., 1996). In the experiment shown, one of five cells responded to bradykinin applications were separated by a 30 min
bradykinin (black line). wash period, 100 nM bradykinin produced a robust re-
(B) The normalized rate constant was plotted versus time for respon-
sponse. Responsive cells were washed for 30 min,sive cells before and during 100 nM bradykinin treatment (horizontal
treated with 5 M CPA, and then four action potential-bar). All recordings were performed in the presence of 5 M CPA.
induced [Ca2]i transients were evoked to determine theApplication of bradykinin started 2 min prior to subsequent field
stimulation. Bradykinin significantly accelerated the rate of Ca2 Ca2 efflux rate under these control conditions. In the
efflux (; n  6), an effect blocked by GF109203x (GF, 2 M, ; presence of CPA, bradykinin-evoked [Ca2]i responses,
n  5). GF109203x and CPA were applied simultaneously (t  30 if present, were small (50 nM) and brief (1 min), con-
min). (***p 0.001, *p 0.05, one-way ANOVA, Bonferroni post hoc
sistent with release from inositol 1,4,5-trisphosphatetest.)
(IP3)-sensitive stores as the main Ca2 source (Thayer(C) 30 or 100 M ATP was applied to fura-2 AM-loaded cells as
et al., 1988). Bradykinin (100 nM) produced a significantindicated by horizontal bars. Neurons were placed in Ca2-free solu-
tion during ATP treatment. The break between the recordings corre- acceleration of Ca2 efflux that reached its maximum
sponds to 25 min. The same criteria as those described in (A) were (k  138%  12% of control; n  6) during the first 2
used to distinguish responsive (black line) from nonresponsive (gray
line) cells.
(D) The normalized rate constant was plotted versus time before
and during ATP treatment (horizontal bar). ATP significantly in- (E) Pharmacology of ATP stimulated Ca2 efflux. Bar graph summa-
creased the rate of Ca2 efflux in control cells (; n  8), but not in rizes the effects of ATP (100 M; gray bars) and UTP (100 M; solid
cells treated with 2 M GF109203x (GF, ; n  5). ATP application bar) on Ca2 efflux in the presence of the indicated antagonists (n
began 2 min prior to field stimulation. GF109203x and CPA were 4–8). Comparisons were made 2 min after agonist application using
applied simultaneously (t  30 min). (*p  0.05, **p  0.01, ***p  the protocol described in (D). (***p  0.001 relative to stimulation
0.001, one-way ANOVA with Bonferroni post hoc test.) with ATP alone, one-way ANOVA with Bonferroni post hoc test.)
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min of treatment (Figure 4B). The B2 receptor antagonist, of PMCA1 were found and PMCA3 was undetectable
(Figure 5A). Based on their relative migration in SDS gelsHOE140 (0.5 M), completely blocked the effects of bra-
(Filoteo et al., 1997), the major alternative splice formsdykinin (n  5; p  0.05, unpaired Student’s t test).
of PMCA2 and PMCA4 in the DRG neurons are 2a andThe bradykinin-induced facilitation of Ca2 efflux was
4b, respectively. In membrane preparations from COSblocked completely by 2 M GF109203x (n 5), indicat-
cells, phosphorylation of PMCA2a by PKC prevents cal-ing that this effect was mediated by PKC (Figure 4B).
modulin binding to this isoform and therefore inhibitsUnlike stimulation with phorbol esters, the acceleration
its activation by Ca2-calmodulin (Enyedi et al., 1997).of Ca2 efflux by bradykinin was transient. This observa-
In contrast, phosphorylation by PKC activated PMCA4btion is in agreement with the transient activation of PKC
in the same preparation (Enyedi et al., 1996). Becauseby bradykinin in DRG neurons (Cesare et al., 1999) and
stimulation of PKC facilitated Ca2 efflux in DRG neu-likely results from receptor desensitization (Dray and
rons, we focused on the PMCA4 isoform.Perkins, 1993).
PMCA4 was distributed throughout sensory neurons.DRG neurons express at least two types of purinergic
Expression of a PMCA4b-GFP fusion protein indicatedreceptors, ionotropic (P2X2 and P2X3) and metabotropic
a widespread distribution of GFP fluorescence, notably(P2Y1) (Cook et al., 1997; Nakamura and Strittmatter,
in axonal varicosities (Figure 5B). These varicosities la-1996). In a subset of DRG neurons, activation of P2Y1
beled positive for synaptophysin, a marker for vesicularreceptors stimulates PLC leading to the production of
release. Similarly, labeling with antibody JA9 indicatedIP3 and DAG (Ralevic and Burnstock, 1998) and the re-
PMCA4 immunoreactivity throughout the cell, includinglease of Ca2 (Svichar et al., 1997). We hypothesized
axonal varicosities that were positive for synaptophysinthat ATP would activate PKC and facilitate Ca2 efflux.
(data not shown).To identify responsive cells, ATP (30 M) was applied
We studied PKC-dependent modulation of Ca2 effluxin Ca2-free medium to avoid Ca2 influx as a result of
in neurons with altered expression of PMCA4. DRG neu-activation of P2X receptors (Cook et al., 1997). Applica-
rons were cotransfected with plasmids that alteredtion of 100 M ATP following a 30 min wash period
PMCA4 levels and a green fluorescent protein (GFP)produced a similar [Ca2]i response (Figure 4C). This
reporter construct using particle-mediated gene deliv-second [Ca2]i transient was completely blocked by a
ery. This method does not alter the electrophysiological25 min pretreatment with 5 M CPA (n  7), confirming
properties or disturb Ca2 metabolism in sensory neu-that ATP released Ca2 from IP3-sensitive Ca2 stores.
rons (Usachev et al., 2000). As shown in Figure 5C, DRGAfter finding a responsive cell and washing for 30 min,
neurons transfected with empty vector and nontrans-it was treated with 5 M CPA and four control [Ca2]i
fected cells showed strong labeling with a PMCA4-transients were elicited using extracellular field stimula-
specific antibody, consistent with high levels of PMCA4tion (Figure 4D). ATP evoked small [Ca2]i increases (50
in these cells. Transfection with a PMCA4 antisensenM) in 11 of 21 cells that rapidly recovered to basal
expression vector (AS4) reduced PMCA4 immunoreac-levels (1 min), suggesting that Ca2 influx induced by
tivity (Figure 5D). AS4 expression did not affect PMCA2activation of P2X receptors was relatively modest under
expression, as indicated by immunolabeling with iso-these recording conditions. These brief [Ca2]i increases
form-specific antibody NR2 (data not shown).had recovered prior to applying the stimulus train and
Neurons transfected with empty vector responded tothus did not interfere with measuring [Ca2]i recovery
PKC activation with an increase in the Ca2 efflux ratekinetics. ATP caused a marked facilitation of Ca2 efflux
to 145%  8% (n  8) of control, in good agreementin DRG neurons (Figure 4D). This facilitation was tran-
with that seen in nontransfected cells (Figure 6A). Thus,sient, probably reflecting desensitization of the recep-
neither the expression vector nor the transfection proce-tors (Ralevic and Burnstock, 1998). The maximal effect
dure affected PKC-dependent facilitation of Ca2 extru-was observed after 2 min of treatment with ATP (k 
sion. Transfection with AS4 did not affect significantly
136%  6% of control; n  8). The PKC antagonist
the rate of Ca2 efflux measured before PDBu treatment.
GF109203x (2 M; n  5) inhibited this facilitation of
The rate constant was 2.1  0.3 min1 (n  11) in AS4-
Ca2 efflux (Figure 4D). ATP-stimulated Ca2 efflux was transfected cells versus 2.2  0.2 min1 (n  20) in
inhibited by the P2 receptor competitive antagonist nontransfected cells (p  0.05, unpaired Student’s t
PPADS (300 M, n  5) and the selective P2Y1 receptor test). However, reduced PMCA4 expression eliminated
antagonist A3P5P (300 M; n  5) (Boyer et al., 1996), the PKC-dependent acceleration of Ca2 efflux, so that
whereas UTP (100 M) did not affect Ca2 efflux kinetics the rate constant remained unchanged (102%  9% of
(n  4), consistent with ATP acting via P2Y1 receptors control; n  11) following 24 min treatment with 0.5
(Ralevic and Burnstock, 1998) (Figure 4E). The ATP- M PDBu (Figure 6A and compare Figure 6B to 6C).
induced acceleration of Ca2 efflux was blocked by the Transfection with the same expression vector harboring
PLC inhibitor U73122 (1M; n 4), but not by its inactive the construct in the sense orientation did not affect
analog U73343 (1 M; n  4) (Figure 4E). PMCA4 immunoreactivity or [Ca2]i recovery kinetics
(n  4).
PMCA4 Mediates PKC-Dependent Facilitation If reduced levels of PMCA4 suppressed the effect of
of Ca2 Efflux PKC activation, then overexpression of PMCA4 could
We next sought to identify the PMCA isoform responsi- be predicted to enhance it. Because the “a” and “b”
ble for PKC-dependent acceleration of Ca2 efflux. splice variants of PMCA4 differ in their carboxy-terminal
Western analysis of a neuron-enriched DRG culture with phosphorylation sites (Enyedi et al., 1996; Verma et al.,
isoform-specific antibodies revealed PMCA2 and 1999), we generated expression constructs for both
hPMCA4a and hPMCA4b and overexpressed the pro-PMCA4 as dominant isoforms, whereas only low levels
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Figure 6. PKC-Dependent Facilitation of Ca2 Efflux in DRG Neu-
rons with Altered Expression of PMCA4
(A) PKC-dependent facilitation of Ca2 efflux was studied as de-
scribed in Figure 3. Transfected cells were identified by distinct
green fluorescence 48 hr after the transfection. PDBu (0.5 M) appli-
cation (horizontal bar above the plots) produced comparable accel-
eration of Ca2 efflux in nontransfected cells (naive, ; n  14) and
cells transfected with an empty vector (; n 8). The effect of PDBu
was significantly diminished in cells expressing AS4 (; n  11).
Cells overexpressing hPMCA4b (4b,H17009; n 6) showed a pronounced
acceleration of Ca2 efflux in response to 0.5 M PDBu. (*p  0.05,
**p  0.01, ***p  0.001, significantly different from naive cells,
Figure 5. PMCA Isoforms in Naive and Genetically Modified DRG ANOVA with Bonferroni post hoc test.)
Neurons (B and C) Representative [Ca2]i traces from cells expressing AS4
(A) PMCA isoforms were analyzed on Western blots of total protein (B) or hPMCA4b (C) before (control) and after treatment with PDBu.
lysates obtained from neuron-enriched DRG cultures (see Experi-
mental Procedures). 40g of protein was loaded in each lane. PMCA
expression was analyzed using the following antibodies: NR1 for and splice variant specific (Figure 5E) (Caride et al.,
PMCA1; NR2 for PMCA2; NR3 for PMCA3; and JA9 for PMCA4
1996). The rate constant in the absence of PDBu was(Caride et al., 1996; Filoteo et al., 1997). The lighter band in the
2.1  0.3 min1 (n  7) for the 4a-expressing neuronsPMCA2 lane is likely the b splice variant. Molecular size markers
are indicated in kDa on the left. and 3.0  0.5 min1 (n  6) for the neurons expressing
(B) Expression of a PMCA4b-GFP fusion protein produced green 4b. Application of 0.5 M PDBu evoked a greater accel-
fluorescence in the axon and soma membranes. Axonal varicosities eration of Ca2 efflux in neurons transfected with
labeled positive for synaptophysin. Merged images show PMCA4b- hPMCA4b than in naive cells (Figures 6A and 6C). In the
GFP colocalized with synaptophysin immunoreactivity.
4b-expressing cells the rate constant reached 170% (C–E) DRG cultures were cotransfected with GFP and an empty
8% of control (n  6) after PDBu treatment, whereas invector (C), a PMCA4 antisense plasmid (AS4) (D), or a plasmid en-
coding hPMCA4b (E) using a “gene gun” (Usachev et al., 2000). Cells the 4a expressing cells the rate constant was compara-
were fixed 48 hr later and labeled with PMCA4-specific antibody JA9 ble to control after the same treatment (n  7; data not
(C and D) or hPMCA4b-specific antibody JA3 (E). White arrows shown). These observations indicate that PKC-depen-
indicate transfected cells identified by GFP labeling. Human-specific dent acceleration of Ca2 efflux in DRG neurons is medi-
antibody JA3 did not label nontransfected rat neurons (asterisks).
ated by PMCA4, likely its b splice variant.
Activation of Bradykinin and Purinergic Receptorsteins in DRG neurons that were subsequently analyzed
using the standard protocol (Figure 3A). Overexpression Shortens the AHP via PKC-Dependent
Acceleration of PMCA4of hPMCA4a was confirmed using PMCA4-specific anti-
body JA9 (not shown), and expression of hPMCA4b was Because PMCAs control the duration of the AHP (Fig-
ures 2D and 2E), we hypothesized that PKC-dependentconfirmed with antibody JA3, which is species (human)
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Ca2-activated K channels were not affected. In DRG
neurons expressing AS4, PDBu did not affect the dura-
tion of the AHP (Figures 7A and 7B). Bradykinin (300
nM) reduced the duration of the AHP by 39% 5% (n
5); this was prevented by pretreatment with GF109203x
(n  5) (Figures 7A and 7B). The P2Y1 receptor agonist
2-methylthio-ATP (2MeSATP; 200 M) reduced the du-
ration of the AHP by 30% 6% (n 5) in a GF109203x-
sensitive manner (n 4; Figures 7A and 7B). Thus, PKC-
dependent acceleration of PMCA4 plays a key role in the
excitation of sensory neurons by bradykinin and ATP.
Discussion
PMCAs are positioned to play a major role in the regula-
tion of Ca2 signaling in neurons. They have a high affin-
ity for Ca2, are distributed throughout the brain, are
localized to presynaptic terminals and dendritic spines,
and colocalize with Ca2 channels. Here we demonstrate
that PMCAs are targets for the modulatory action of
neurotransmitters and neuroactive peptides. Bradykinin
and ATP activate PKC with subsequent acceleration of
Ca2 efflux from rat DRG neurons. Analysis of PKC-
induced changes in [Ca2]i dynamics in neurons with
altered PMCA4 expression indicated that this isoform,
and specifically its splice variant b, mediated the PKC-
dependent enhancement of Ca2 efflux. The signaling
pathway described here, metabotropic receptor activa-
tion, phosphorylation of PMCA by PKC, and an increase
in the Ca2 efflux rate, provides an example of what may
be a general model for the modulation of [Ca2]i efflux
in neurons (Figure 7C).
Figure 7. Activation of PKC Shortens the AHP via PMCA4 Activation of Metabotropic Receptors
(A) Membrane potential was recorded from DRG neurons stimulated Accelerates Ca2 Efflux
with depolarizing current injections (3–5 s, 5–10 Hz). The perforated-
Bradykinin and ATP markedly accelerated Ca2 effluxpatch technique was used to prevent intracellular dialysis, and CPA
via a PKC-dependent pathway in DRG neurons. Thesewas omitted to improve membrane stability in this configuration.
results agree with an established signaling cascade inRecordings from nontransfected (upper) and AS4-expressing cells
(lower) are shown before (control) and 10 min after 0.5 M PDBu. which bradykinin activation of B2 receptors increases
Representative AHPs are shown (upper row) before (control) and 4 DAG production and activates PKC (Burgess et al., 1989;
min after 300 nM bradykinin (Bk) or 200 M 2MeSATP as indicated. Cesare et al., 1999; Dray and Perkins, 1993; Stucky et
In the presence of 0.5 M GF109203x (GF), agonists failed to affect
al., 1996; Thayer et al., 1988). Similarly, our data indicatethe response (lower row). Agonist-responsive cells were selected
that P2Y1 receptors in sensory neurons couple to phos-using [Ca2]i imaging as described for Figure 4.
pholipase C and activate PKC. Activation of either B2(B) Bar graph summarizes AHP recovery times normalized to the
initial control response from untreated (open), GF109302x-treated or P2Y1 receptors sensitizes DRG neurons to external
(gray), and AS4-expressing (solid) cells. (*p 0.05, **p 0.01, ***p stimuli by PKC-dependent phosphorylation of proteins
0.001, relative to untreated response, Student’s t test.) that control excitability (Burgess et al., 1989; Dray and
(C) A model for acceleration of Ca2 efflux by bradykinin and ATP.
Perkins, 1993; Nakamura and Strittmatter, 1996; Tomi-Binding of bradykinin to B2 or ATP to P2Y1 receptors activates Gq
naga et al., 2001). DRGs contain a heterogeneous popu-and PLC
. This leads to production of DAG and activation of PKC.
lation of neurons specialized to convey different sensoryPKC phosphorylates PMCA4b near the carboxyl terminus, resulting
in acceleration of Ca2 transport by the pump. Changes in Ca2 modalities and are characterized by unique electrophys-
efflux alter [Ca2]i-dependent activation of K channels. iological, pharmacological, and morphological proper-
ties. Bradykinin receptors are found preferentially on
small-size DRG neurons involved in nociception and
characterized by immunoreactivity to substance P (Drayfacilitation of Ca2 efflux would shorten the AHP. Mem-
brane potential was recorded with the perforated patch- and Perkins, 1993; Stucky et al., 1996). P2Y1 receptors
are found on nociceptive and proprioceptive neuronsclamp technique, and AHPs were evoked by trains of
action potentials similar to those used for Ca2 efflux (Nakamura and Strittmatter, 1996; Tominaga et al.,
2001). Therefore, the effects of bradykinin and ATP aremeasurements. PDBu (0.5 M) reduced the duration (t1/2)
of the AHP (Figures 7A and 7B) by 41%  3% (n  9). limited to subpopulations of sensory neurons. However,
phorbol esters produced a comparable effect in DRGThis effect was completely prevented by pretreatment
with 5 M GF109203x (n  4). PDBu did not alter the neurons from a broad range of sizes (15–27 m) and
ages in the culture (2–18 days). This observation impliesamplitude of the AHP (8  1mV; n  9), suggesting that
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that PKC-dependent facilitation of Ca2 efflux is a gen- certain PMCA isoforms can disrupt neuronal differentia-
tion (Brandt et al., 1996) or lead to hearing and balanceeral phenomenon, typical for the majority of sensory
neurons. deficits (Kozel et al., 1998; Street et al., 1998). Here we
found that modulation of PMCA-mediated Ca2 efflux
controlled the duration of the AHP following a train ofPMCA Isoform Diversity Produces
action potentials. The slow AHP is generated by Ca2-Functional Specialization
activated K channels (Sah, 1996) and is responsibleAlternative splicing of PMCA transcripts generates Ca2
for the slowing of firing rate known as spike frequencypumps with diverse regulatory properties (Strehler and
adaptation (Hille, 1992). Bradykinin shortened the AHPZacharias, 2001). PKC-induced facilitation of PMCA-
by accelerating Ca2 efflux, an effect that could accountmediated Ca2efflux was previously described for endo-
for its ability to reduce spike-frequency adaptation inthelial cells (Wang et al., 1991) and Jurkat T cells (Balasu-
DRG neurons (Cordoba-Rodriguez et al., 1999). The in-bramanyam and Gardner, 1995), although the specific
creased excitability and loss of spike frequency adapta-PMCA isoform responsible for this effect was not identi-
tion produced by bradykinin underlies sensitization offied. Here we identify the PMCA isoform that is responsi-
peripheral nociceptors. ATP sensitizes DRG neurons toble for this facilitation in an intact cell. Knockdown of
touch and heat, and the PMCA-mediated shortening ofthe PMCA4 isoform virtually eliminated PKC-dependent
the AHP described here may contribute to these excit-facilitation of Ca2 efflux. In contrast, overexpression of
atory responses (Nakamura and Strittmatter, 1996; To-the b but not the a splice variant of PMCA4 enhanced
minaga et al., 2001).the stimulatory effect of PDBu on Ca2 efflux. Thus,
The presynaptic location of PMCAs (Juhaszova et al.,PMCA4b is a molecular target for PKC following activa-
2000; Zenisek and Matthews, 2000), their participationtion by bradykinin or ATP in DRG neurons. In agreement
in [Ca2]i regulation at axonal release sites (Figures 3with this, the 4b splice variant is one of the major PMCA
and 5), and their colocalization with voltage-gated Ca2isoforms expressed endogenously in DRG neurons. Our
channels (Hillman et al., 1996) imply that modulation ofresults are also in good agreement with those obtained
Ca2 pumps may regulate neurotransmitter release. Thefrom membrane preparations from COS cells overex-
high affinity of PMCAs for Ca2 may enable them topressing PMCA4a or PMCA4b (Enyedi et al., 1996;
play an important role in controlling residual Ca2 andVerma et al., 1999). PKC phosphorylates the a variants
delayed neurotransmitter release. The extent and direc-of PMCA2, PMCA3, and PMCA4 within the calmodulin
tion of the changes in Ca2 efflux is determined by thebinding domain (Enyedi et al., 1997; Verma et al., 1999).
specific PMCA isoforms present at the release site.Phosphorylation of PMCA2a and PMCA3a by PKC pre-
vents binding of calmodulin and, therefore, activation
Conclusionsof these isoforms (Enyedi et al., 1997), whereas phos-
phorylation of PMCA4a appears to be without conse-
We have shown that a specific PMCA isoform is stimu-quence for its basal activity or calmodulin stimulation
lated by neuromodulators. Thus, Ca2 pumps play a(Verma et al., 1999). In contrast, PKC phosphorylates
more dynamic and specialized role in neuronal functionPMCA4b at a site downstream from the calmodulin bind-
than their previously ascribed role as mere housekeep-ing domain and enhances Ca2 pump activity (Enyedi
ers of [Ca2]i homeostasis. Modulation of Ca2 effluxet al., 1996). Clearly, the specific expression pattern of
was found to control excitability in DRG neurons andPMCA variants determines the net effect of phosphory-
could potentially affect many processes sensitive tolation on Ca2 efflux.
basal [Ca2]i and the duration of [Ca2]i transients. TheThe role of specific PMCA isoforms in the nervous
heterogeneous distribution of PMCA isoforms differingsystem is largely unknown. We found that PMCA4 con-
in their sensitivity to modulation suggests that Ca2tributed significantly to Ca2 efflux after phosphorylation
pumps create local domains tuned to specific signalingby PKC and thus may play a special role in translating
needs.extracellular signals into Ca2-dependent events within
neurons. In contrast, PMCA2 is more active than PMCA4
Experimental Proceduresat basal [Ca2]i (Elwess et al., 1997), consistent with the
idea that this pump is important for maintaining resting
Cell Culture
[Ca2]i. Another feature of PMCA4b is its carboxy-termi- Rat DRG neurons were grown in culture as described (Werth and
nal PDZ binding domain that may allow the pump to be Thayer, 1994). DRG neurons with cell body diameters of 18–27 m
clustered with other receptors, transporters, and signal- were used within 2–3 days after plating unless indicated otherwise.
For cocultures, spinal neurons were isolated as previously describeding molecules at specific membrane regions within a
(Abrahams et al., 1999) and mixed with DRG neurons (1:1) beforeneuron (Kim et al., 1998). This may make facilitation of
plating onto laminin-coated coverslips. Cocultures were grown inCa2 efflux by PKC more dramatic within these microdo-
equal parts DRG and spinal neuron media.
mains relative to that observed in recordings from the
bulk cytoplasm. PKC-dependent modulation of PMCA4b [Ca2]i Measurements and Patch-Clamp Recordings
in sensory neurons demonstrates how the functional [Ca2]i recordings from single DRG neurons using indo-1 or fura-
2-based microfluorimetry and whole-cell patch-clamp recordingsspecialization of PMCA isoforms provides precise tem-
were performed as described (Jin et al., 1994; Usachev and Thayer,poral control of [Ca2]i signals in neurons.
1999). To image [Ca2]i in axons, dye was introduced into single
neurons via patch pipettes (0.5 mM). Cells were held in the whole-
PMCAs and Neuronal Function cell configuration for 3 min, the pipette withdrawn, and recordings
The significance of PMCAs to neuronal function has only made 1–1.5 hr later. Patch pipettes (2–4 M) were filled with the
following solution: 125 mM KGluconate, 10 mM KCl, 3 mM Mg-ATP,recently become appreciated. Genetic suppression of
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1 mM MgCl2, 10 mM HEPES, 0.08 mM indo-1 (pH 7.25 with KOH, by centrifuging for 5 min at 13,000  g. Samples were analyzed by
Western blot as described (Usachev et al., 2001).290 mOsm/kg with sucrose). For perforated patch recordings, the
pipette contained: 135 mM KGluconate, 10 mM NaCl, 10 mM HEPES,
200 g/ml amphotericin B (pH 7.25 with KOH, 290 mOsm/kg). Extra- Reagents
cellular recording solution contained: 140 mM NaCl, 5 mM KCl, 1.3 Indo-1, indo-1 AM, fura-2 AM, and Pluronic F-127 were obtained
mM CaCl2, 0.4 mM MgSO4, 0.5 mM MgCl2, 0.4 mM KH2PO4, 0.6 mM from Molecular Probes (Eugene, OR). GF109203x, Ro31-8220, and
Na2HPO4, 3 mM NaHCO3, 10 mM HEPES, 10 mM glucose (pH 7.35 PDBu were obtained from Calbiochem (San Diego, CA). All other
with NaOH, 310 mOsm/kg with sucrose). To evoke action potentials reagents were purchased from RBI/Sigma (St. Louis, MO).
in intact neurons, extracellular field stimulation was employed
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